Bellerophon Therapeutics
BLPH
$0.05540
Share price
0.73%
Change (1 day)
-99.27%
Change (1 year)
Categories
EPS for Bellerophon Therapeutics (BLPH)
EPS in 2023 (TTM): -$1.21
According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.21. In 2022 the company made an earnings per share (EPS) of -$2.08 a decrease over its 2021 EPS that were of -$1.88.
EPS history for Bellerophon Therapeutics from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.21 | -41.83% |
| 2022 | -$2.08 | 10.64% |
| 2021 | -$1.88 | -42.86% |
| 2020 | -$3.29 | 12.67% |
| 2019 | -$2.92 | -500% |
| 2018 | $0.73 | -103.53% |
| 2017 | -$20.70 | -13.75% |
| 2016 | -$24.00 | -48.13% |
| 2015 | -$46.27 | 882.98% |
| 2014 | -$4.71 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $2.97 | -345.64% | 🇺🇸 USA |
 Baxter BAX | $5.12 | -523.14% | 🇺🇸 USA |
 Lantheus Holdings LNTH | $1.53 | -226.45% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | -$3.00 | 148.23% | 🇺🇸 USA |